When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Targeting a market that could reach $1.1 trillion by 2050, Cortexyme (CRTX) will probably interest institutional investors. Besides, the company appears to have sufficient equity financing to complete its Phase 2-3 clinical trial. In addition, the fact that Pfizer (PFE) is among the shareholders is also very appealing. The only issue is that the company expects to deliver top-line results in 2021. The market will have to wait for more than two years, which is a long time for some investors.